05:45:36 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-11-07 Kvartalsrapport 2024-Q3
2024-08-15 Kvartalsrapport 2024-Q2
2024-05-08 Ordinarie utdelning QLIFE 0.00 SEK
2024-05-07 Årsstämma 2024
2024-05-07 Kvartalsrapport 2024-Q1
2024-02-08 Bokslutskommuniké 2023
2024-01-16 Extra Bolagsstämma 2023
2023-11-13 Kvartalsrapport 2023-Q3
2023-08-17 Kvartalsrapport 2023-Q2
2023-05-26 Kvartalsrapport 2023-Q1
2023-05-05 Ordinarie utdelning QLIFE 0.00 SEK
2023-05-04 Årsstämma 2023
2023-03-24 Extra Bolagsstämma 2022
2023-02-16 Bokslutskommuniké 2022
2022-11-25 Kvartalsrapport 2022-Q3
2022-08-29 Kvartalsrapport 2022-Q2
2022-05-06 Ordinarie utdelning QLIFE 0.00 SEK
2022-05-05 Kvartalsrapport 2022-Q1
2022-05-05 Årsstämma 2022
2022-02-17 Bokslutskommuniké 2021
2021-11-08 Kvartalsrapport 2021-Q3
2021-08-16 Kvartalsrapport 2021-Q2
2021-05-06 Ordinarie utdelning QLIFE 0.00 SEK
2021-05-05 Årsstämma 2021
2021-05-05 Kvartalsrapport 2021-Q1
2021-02-18 Bokslutskommuniké 2020
2020-11-19 Extra Bolagsstämma 2020
2020-11-18 Kvartalsrapport 2020-Q3
2020-08-18 Kvartalsrapport 2020-Q2
2020-05-22 Ordinarie utdelning QLIFE 0.00 SEK
2020-05-20 Årsstämma 2020
2020-05-20 Kvartalsrapport 2020-Q1

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
Qlife Holding är verksamt inom medicinteknik. Bolaget är specialiserat inom forskning och utveckling av IVD-enheter. Enheterna används som biomarkörstester i blod och används som komplement till övriga tester inom vården. Samarbete utförs även med övriga aktörer på marknaden. Störst verksamhet återfinns inom den nordiska marknaden, med huvudkontoret i Helsingborg.
2021-06-09 12:30:00

The four founders of Qlife - Thomas Warthoe, Peter Warthoe, Lars Bangsgaard and Ebbe Finding - have previously owned their shares in Qlife, in total 3,900,000 shares, via a jointly owned company, PKV Consult IVS. They have now divided the ownership into four different, own companies.

The division means that Thomas Warthoe's, Peter Warthoe's and Lars Bangsgaard's respective companies have acquired 1,201,200 shares each from PKV Consult IVS, and Ebbe Finding is now the sole owner of PKV Consult IVS, where he owns 296,400 shares in Qlife. After the transactions:
  • Thomas Warthoe is the largest owner in Qlife through his company with approximately 9.7 percent of capital and votes.
  • Peter Warthoe and Lars Bangsgaard are separately and via their respective companies second largest owners with approximately 7.8 percent each, and
  • With its 1.9 percent via PKV Consulting IVS, Ebbe Finding is the company's nineth largest owner.

The above ownership distribution is calculated after the issue of shares subscribed for using TO1, which is expected to be registered shortly. The transactions of the shares were carried out on June 9th. The lock-up agreement that was entered into in connection with the private placement in April 2021 continues to apply to PKV Consult IVS and now also applies to Thomas Warthoes, Peter Warthoes and Lars Bangsgaard's respective companies.